Advertisement

Acta Diabetologica

, Volume 55, Issue 5, pp 479–484 | Cite as

The risk of type 2 diabetes mellitus according to the categories of body mass index: the Korean Genome and Epidemiology Study (KoGES)

  • Ju Young Jung
  • Sung Keun Park
  • Chang Mo Oh
  • Jae-Hong Ryoo
  • Joong-Myung Choi
  • Young Joon Choi
Original Article
  • 213 Downloads

Abstract

Aims

Obesity is an established risk factor for type 2 diabetes mellitus (T2DM). However, there is limited information on the pattern of relationship between the risk for T2DM and body mass index (BMI) categories including underweight and overweight. Thus, this study was to evaluate the risk of T2DM according to BMI categories defined by Asian-specific cutoff of BMI.

Methods

7660 non-diabetic Koreans were grouped into five BMI categories (underweight, normal, overweight, obese and severe obese) defined by Asian-specific cutoff of BMI and followed up for 10 years to monitor the development of T2DM. With a reference of normal BMI group, Cox proportional hazards assumption was used to calculate hazard ratios (HRs) and their 95% confidence intervals for T2DM in five groups. Subgroup analysis was conducted by gender and age (40–59 years and 60–69 years).

Results

Baseline mean value of metabolic factors like fasting glucose, HOMA-IR, total cholesterol and the proportion of impaired fasting glucose increased proportionally to the level of BMI categories. Underweight group had the higher proportion of impaired glucose tolerance than normal and overweight group. In all subgroups, underweight, overweight, obese and severe obese group had the higher HRs for T2DM than normal group, but statistical significance was only found in overweight, obese and severe obese group.

Conclusions

The risk of T2DM tends to increase proportionally to the level of BMI categories from overweight to severe obese group. Further studies should be considered to identify the incidental relationship between underweight and T2DM.

Keywords

Body mass index Underweight Obesity and type 2 diabetes mellitus 

Notes

Acknowledgements

Data in this study were from the Korean Genome and Epidemiology Study (KoGES; 4851-302), National Research Institute of Health, Centers for Disease Control and Prevention, Ministry for Health and Welfare, Republic of Korea. Therefore, this study could be done by virtue of the labor of all staffs working in KoGES.

Author’s contribution

Ju Young Jung coordinated the study, analyzed the data and wrote the manuscript as a first author. Chang-Mo Oh played role in analyzing data and verifying the results. Jae-Hong Ryoo participated in conducting study and writing manuscript. Joong-Myung Choi participated in English editing and reviewing manuscript. Young-Jun Choi has a role in monitoring study process and making manuscript. Sung Keun Park is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Compliance with ethical standards

Conflict of interest

Nothing to be declared. The authors report no relationships that could be construed as a conflict of interest.

Human and animal rights

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Supplementary material

592_2018_1112_MOESM1_ESM.docx (18 kb)
Supplementary material 1 (DOCX 18 kb)

References

  1. 1.
    Haslam DW, James WP (2005) Obesity. Lancet 366:1197–1209CrossRefPubMedGoogle Scholar
  2. 2.
    Jensen MD, Ryan DH, Apovian CM et al. (2013) AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity SocietyGoogle Scholar
  3. 3.
    American Diabetes Association (2016) Standards of medical care in diabetes 2016. Diabetes Care 39(Suppl 1):S13Google Scholar
  4. 4.
    Eckel RH, Kahn SE, Ferrannini E et al (2011) Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care 34:1424–1430CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846CrossRefPubMedGoogle Scholar
  6. 6.
    Grundy SM (2004) Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595–2600CrossRefPubMedGoogle Scholar
  7. 7.
    Hu FB, Manson JE, Stampfer MJ et al (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797CrossRefPubMedGoogle Scholar
  8. 8.
    Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMedGoogle Scholar
  9. 9.
    Thinggaard M, Jacobsen R, Jeune B, Martinussen T, Christensen K (2010) Is the relationship between BMI and mortality increasingly U-shaped with advancing age? A 10-year follow-up of persons aged 70–95 years. J Gerontol A Biol Sci Med Sci 65:526–531CrossRefPubMedGoogle Scholar
  10. 10.
    Adams KF, Schatzkin A, Harris TB et al (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778CrossRefPubMedGoogle Scholar
  11. 11.
    Hioki H, Miura T, Motoki H et al (2015) Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease. Heart Asia 7:12–18CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Sairenchi T, Iso H, Irie F, Fukasawa N, Ota H, Muto T (2008) Underweight as a predictor of diabetes in older adults: a large cohort study. Diabetes Care 31:583–584CrossRefPubMedGoogle Scholar
  13. 13.
    Razak F, Anand SS, Shannon H et al (2007) Defining obesity cut points in a multiethnic population. Circulation 115:2111–2118CrossRefPubMedGoogle Scholar
  14. 14.
    Shai I, Jiang R, Manson JE et al (2006) Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 29:1585–1590CrossRefPubMedGoogle Scholar
  15. 15.
    Chen Y, Copeland WK, Vedanthan R et al (2013) Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium. BMJ 347:f5446CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Ni Mhurchu C, Rodgers A, Pan WH, Gu DF, Woodward M, Asia Pacific Cohort Studies Collaboration (2004) Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol 33:751–758CrossRefPubMedGoogle Scholar
  17. 17.
    World Health Organization, International Obesity Task Force (2000) The Asian-Pacific perspective: redefining obesity and its treatment. WHO Western Pacific Region, GenevaGoogle Scholar
  18. 18.
    WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRefGoogle Scholar
  19. 19.
    Han SJ, Kim HJ, Kim DJ, Lee KW, Cho NH (2017) Incidence and predictors of type 2 diabetes among Koreans: a 12-year follow up of the Korean Genome and Epidemiology Study. Diabetes Res Clin Pract 123:173–180CrossRefPubMedGoogle Scholar
  20. 20.
    Kim Y, Han BG, KoGES group. Cohort Profile (2016) The Korean genome and epidemiology study (KoGES) Consortium. Int J Epidemiol 46:e20CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Gu D, He J, Duan X et al (2006) Body mass index and mortality among men and women in China. JAMA 295:776–783CrossRefPubMedGoogle Scholar
  22. 22.
    Tsugane S, Sasaki S, Sasaki y, Tsubono Y for the JPHC Study Group (2002) Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC Study cohort I. Int J Obes Relat Metab Disord 26:529–537CrossRefPubMedGoogle Scholar
  23. 23.
    Jee SH, Sull JW, Park J et al (2006) Body-mass index and mortality in Korean men and women. N Engl J Med 355:779–787CrossRefPubMedGoogle Scholar
  24. 24.
    Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M (2009) Rationale for redefining obesity in Asians. Ann Acad Med Singapore 38:66–69PubMedGoogle Scholar
  25. 25.
    Ko KP, Oh DK, Min H et al (2012) Prospective study of optimal obesity index cutoffs for predicting development of multiple metabolic risk factors: the Korean genome and epidemiology study. J Epidemiol 22:433–439PubMedPubMedCentralGoogle Scholar
  26. 26.
    Godsland IF, Jeffs JA, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157–1166CrossRefPubMedGoogle Scholar
  27. 27.
    Kanat M, Mari A, Norton L et al (2012) Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance. Diabetes 61:447–453CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Ferrannini E, Gastaldelli A, Miyazaki Y et al (2003) Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211–1219CrossRefPubMedGoogle Scholar
  29. 29.
    Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51:S221–S226CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  • Ju Young Jung
    • 1
  • Sung Keun Park
    • 2
  • Chang Mo Oh
    • 3
  • Jae-Hong Ryoo
    • 3
  • Joong-Myung Choi
    • 3
  • Young Joon Choi
    • 4
  1. 1.Total Healthcare Center, Kangbuk Samsung HospitalSungkyunkwan University School of MedicineSeoulRepublic of Korea
  2. 2.Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung HospitalSungkyunkwan University School of MedicineSeoulRepublic of Korea
  3. 3.Departments of Preventive Medicine, School of MedicineKyung Hee UniversitySeoulRepublic of Korea
  4. 4.Department of Dermatology, Kangbuk Samsung HospitalSungkyunkwan University School of MedicineSeoulRepublic of Korea

Personalised recommendations